The 2026 AHA/ASA Acute Ischemic Stroke Guideline: What Changed for the Pharmacist, the Hospitalist, and the Order Set

Cefepime vs. Piperacillin-Tazobactam for Pseudomonas Pneumonia

The 2026 IDSA AMR Guidance: What Changed, Why It Changed, and What You Do Monday Morning

The Contrast Nephropathy That Wasn't

Staphylococcus aureus Bacteremia in 2026: A New Guideline, a Landmark Trial, and What It Means at the Bedside

PharmaCompass InPHARMation is for educational purposes only and does not constitute medical advice. Always verify clinical information before applying to patient care. Full Disclaimer | © 2026 PharmaCompass Education, LLC

Read more

Cefepime vs. Piperacillin-Tazobactam for Pseudomonas Pneumonia

The 2026 IDSA AMR Guidance: What Changed, Why It Changed, and What You Do Monday Morning

The Contrast Nephropathy That Wasn't

Staphylococcus aureus Bacteremia in 2026: A New Guideline, a Landmark Trial, and What It Means at the Bedside